Related Experiment Video
Updated: Aug 3, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
[Epilepsy in Children]
1Epilepsy Center, TMG Asaka Medical Center.
Insights
Childhood epilepsy presents age-dependent syndromes, categorized by prognosis. Some forms are self-limited, while others become pharmacoresistant, leading to developmental epileptic encephalopathy and lifelong care needs.
Area of Science:
- Pediatric Neurology
- Epileptology
- Developmental Neuroscience
Context:
- Childhood epilepsy comprises distinct syndromes tied to developmental stages.
- Syndromes are classified as self-limited with good prognosis or pharmacoresistant with poor prognosis.
- Pharmacoresistant epilepsy often begins in infancy, progressing to developmental epileptic encephalopathy.
Purpose:
- To delineate the characteristics and progression of age-dependent epilepsy syndromes in children.
- To distinguish between prognostically different epilepsy categories.
- To highlight the long-term care requirements for children with pharmacoresistant epilepsy.
Summary:
- Epilepsy syndromes in children vary with age, falling into self-limited or pharmacoresistant categories.
- Pharmacoresistant epilepsy, despite lower prevalence, carries a poor prognosis and can lead to significant developmental disabilities.
- Children with persistent pharmacoresistant epilepsy require ongoing, comprehensive medical care into adulthood.
Impact:
- Improved understanding of epilepsy progression in pediatric populations.
- Informed clinical management strategies for different childhood epilepsy syndromes.
- Enhanced planning for lifelong care transitions for affected individuals.
Abstract:
Childhood epilepsy is characterized by specific epilepsy syndromes that occur during each developmental age. These "age-dependent" epilepsy syndromes are clinically categorized into a self-limited epilepsy group with good prognosis and high prevalence rate and a pharmacoresistant epilepsy group with poor prognosis despite low prevalence rates. Many children develop pharmacoresistant epilepsy beginning in early infancy and progress to developmental epileptic encephalopathy, which is associated with intellectual, behavioral, and/or motor disabilities. These children do not show remission in epilepsy and are transitioned to the adult service and require comprehensive medical care.
More Related Videos
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
07:01Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists